Why Software Testing Is a Patient Safety Issue, Not Just a QA Requirement

By Your Health Magazine

Your Health Magazine

. http://yourhealthmagazine.net

More Health Technology Articles

Why Software Testing Is a Patient Safety Issue, Not Just a QA Requirement

Most industries experience operational problems due to software failures. In the healthcare sector, these problems are known as clinical ones.

Examples include a medication order showing the incorrect dose, a clinical alert not triggering when a patient is deteriorating, and EHR integration losing lab results en route to their destination. These are not hypothetical edge cases. These are all recorded failure modes in deployed healthcare software, and they all stem from one thing: testing that was not designed based on the clinical implications of what it was testing.

The standard QA toolkit – functional testing, regression testing, and simple integration testing is not inappropriate for healthcare software. It is just insufficient. Clinical settings present failure modes, regulatory demands and patient safety issues that cannot be handled by standard testing methods.

How Software Failures in Healthcare Create Patient Safety Risk

Healthcare software is used in an environment where the cost of failure is not measured in support tickets, but in clinical outcomes. This changes what the testing must discover and the cost when it does not.

Clinical Decision Support and Medication Safety

Clinical decision support systems bridge the gap between software reliability and direct patient care. A CDS alert is effective when it triggers an alert regarding a drug interaction or abnormal result. However, if the alert is not triggered due to incorrect logic, stale data, or an incorrectly configured alert threshold in a recent update, the clinician continues without the information that the system was designed to provide.

The more difficult failure mode to test is the alarm that goes off when it is not supposed to. The issue of alert fatigue is already a major issue in clinical practice – clinicians in high-volume settings are trained to ignore alerts that go off regularly and randomly. A software update that increases the alert triggering conditions is part of a trend where actual alerts are ignored, as well as false alerts. The software successfully went through functional testing. The clinical outcome was due to a usage pattern that the test suite had never modeled.

The most direct pathway to harm is medication safety failures. For example, a dosing infusion pump that computes dosing based on a weight field with incorrect unit conversion – kilograms instead of pounds – can deliver a dose 2.2 times the intended amount. These failures have a similar testing gap: the logic of the calculation is tested with anticipated inputs rather than with the actual data entry patterns that clinical users generate under time pressure.

Data Integrity and Interoperability Failures

An integration defect is a sync failure between an outpatient EHR and a hospital system that loses an allergy list of a patient. Clinically, it is a possible adverse drug event – the wait until a provider orders a drug without the knowledge of the allergy in the outpatient record.

HL7- and FHIR-based interoperability introduces the issue that messages which are semantically valid but contain clinically incorrect data are lacking in standard integration testing. For example, a laboratory report that is successfully transmitted but mapped to the incorrect patient record, or a diagnostic code with a different translation in the code sets of two systems, would each pass a simple integration test. However, none of them passes a clinical validation test since the transmission itself does not fail. It is what the data is when it arrives.

For healthtech teams where standard software testing services haven’t been adapted for clinical environments, the gap between what’s being tested and what needs to be tested is often where patient safety risk lives.

What Healthcare Software Testing Actually Needs to Cover

The distinction between standard and healthcare software testing is not necessarily rigor, but a frame. Normal testing poses the question of whether the software is doing what it was intended to do. Healthcare testing poses the question of whether it is safe in a clinical setting where failures go beyond the product itself.

Risk-based testing to IEC 62304 and ISO 14971 is risk-based testing that is aligned to clinical hazards instead of functional requirements: what might go wrong, what is the clinical impact, and how probable is the clinical impact to reach a patient? A high-risk medication calculation module needs more coverage than a report export feature – no matter how recently each of them was changed. The risk rationale of coverage decisions is not only documented in the results but also in the documentation since the documentation is a subset of the safety argument.

HIPAA security testing is not just like normal application security. Audit log integrity testing ensures that all the access to the secured health information is recorded with the necessary fields. Role-based controls are tested by minimum necessary access testing. Breach scenario simulation tests are used to test the software in cases of unauthorized access. Both of them have certain documentation requirements that cannot be separated in terms of test execution and documentation.

The domain expertise is the distinguishing factor in clinical scenario testing. Written test cases lack clinical context and include workflows that the development team outlined – and omit those used by clinical users. A medication ordering process that seems to be linear in specifications is never interrupted in reality: patient identification checks, alert response, and external reference checks. Failure modes of such interrupted sequences do not manifest themselves in test cases that are written using a specification. They are revealed when a tester who has clinical knowledge explores the areas where the users are going off the happy path.

Clinical software regression needs a standard of clinical risk map strategies that are not part of the standard strategies. Even a single line modification to a dosing calculation formula would need regression coverage of all clinical situations in which the calculation is applied. Code change impact-based standard regression scoping systematically under-covers these scenarios since it does not have the clinical context to be aware of what is downstream.

For teams evaluating specialized testing support, a ranked link of healthcare software testing services gives a useful benchmark for what clinically experienced, regulatory-aware providers look like across methodology and domain expertise.

Conclusion

Failure in healthcare software testing occurs when testing is based on software quality measures rather than clinical risk. Passing functional and integration tests does not guarantee that the software is safe if the coverage was not designed based on failure modes that have the potential to cause patient harm.

Regulatory standards such as IEC 62304, ISO 14971, HIPAA and FDA SaMD guidance are not just bureaucratic overhead. They provide written knowledge of where software malfunctions in clinical settings have historically caused patient injury and what testing must cover.

Teams that view testing as a patient safety activity rather than a release gate will benefit from fewer post-deployment clinical incidents, cleaner regulatory submissions and a testing practice that develops institutional knowledge of clinical risk over time.